Page last updated: 2024-08-22

angiotensin ii and sb 239063

angiotensin ii has been researched along with sb 239063 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boomsma, F; de Boer, RA; Flesch, M; Pinto, YM; Pokharel, S; Suurmeijer, AJ; van Gilst, WH; van Kampen, DA; van Veldhuisen, DJ1
Aravindhan, K; Bernard, RE; Boyce, R; Jucker, BM; Mirabile, RC; Morris, JB; Olzinski, AR; Willette, RN1

Other Studies

2 other study(ies) available for angiotensin ii and sb 239063

ArticleYear
Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27.
    Journal of molecular medicine (Berlin, Germany), 2004, Volume: 82, Issue:10

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Collagen Type I; Disease Models, Animal; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; Fibrosis; Heart Failure; Homozygote; Hypertrophy, Left Ventricular; Imidazoles; Immunohistochemistry; Male; Mitogen-Activated Protein Kinases; Myocardium; Protein-Tyrosine Kinases; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Renin; Smad Proteins; Tetrazoles; Time Factors; Trans-Activators; Tyrphostins

2004
p38 MAPK inhibition reduces aortic ultrasmall superparamagnetic iron oxide uptake in a mouse model of atherosclerosis: MRI assessment.
    Arteriosclerosis, thrombosis, and vascular biology, 2008, Volume: 28, Issue:2

    Topics: Angiotensin II; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Contrast Media; Enzyme Inhibitors; Feasibility Studies; Ferrosoferric Oxide; Imidazoles; Inflammation; Magnetic Resonance Angiography; Male; Metal Nanoparticles; Mice; Mice, Knockout; p38 Mitogen-Activated Protein Kinases; Pyrimidines; Vasoconstrictor Agents

2008